Company intelligence / Profile preview

Sanifruit

Ownership: Private
Development stage: Commercial

Overview

Sanifruit has over 35 years of experience developing natural residue-free post-harvest solutions that extend shelf life and reduce waste for fruits such as citrus, stone fruits, avocados, tomatoes, peppers, and blueberries. Their products are used by major exporters to meet strict European standards for residue limits.

Therapeutic areas: Other
Modalities: Non-pharmacological therapy
Industry: Agriculture & AgTech

Partnerships

Collaborates with European fruit exporters/packers but no major pharma/biotech partnerships reported.

Beyond the preview

Go deeper on Sanifruit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanifruit.

Explore the full profile